# ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)

> **NCT01748253** · NA · UNKNOWN · sponsor: **Acrobat Trial Group** · enrollment: 80 (estimated)

## Conditions studied

- Hypertension and Atrial Fibrillation

## Interventions

- **DRUG:** Telmisartan-amlodipine tablet administration group (morning)
- **DRUG:** Telmisartan-amlodipine tablet administration group (bedtime)

## Key facts

- **NCT ID:** NCT01748253
- **Lead sponsor:** Acrobat Trial Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01748253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01748253, "ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01748253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*